KLYG
Kelyniam Global, Inc.
$0.16
+0.03 (+23.08%)
At close · Jul 6
Market Cap
$8.02M
Shares
50,123,430
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.16
Open$0.15
Day$0.15–0.16
52W$0.05–0.30
Avg vol 30d6K
Short int502 · 0.0% float · 1.0d
Short vol86%
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+25% above
+
Price vs 50-day avg
+17% above
◦
RSI (14)
60 · neutral
−
MACD trend
negative
◦
52-week position
44% · mid-range
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $0 › 200d $0 — 50d above 200d
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.00% of float · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+25% above
Bullish
Price vs 50-day avg
+17% above
Bullish
RSI (14)
60 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
44% · mid-range
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 44%
52-wk high $0
vs 200-day avg +25%
vs 50-day avg +17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KLYG
this stock
Kelyniam Global, Inc.
|
$8.02M | +33.3% | — | — | 0.0% |
|
ABT
Abbott Laboratories
|
$166.57B | -23.3% | +5.7% | 26.8 | 1.3% |
|
SYK
Stryker Corp
|
$124.49B | -7.4% | +11.2% | 37.6 | 1.6% |
|
MDT
Medtronic plc
|
$106.32B | -12.8% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.62B | -53.2% | +5.5% | 19.0 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KLYG | +6.7% | +23.1% | +33.3% | +0.0% | +33.3% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | +3.6% | +23.9% | +25.1% | -0.6% | +23.2% |